PppApG

PppApG is a starting product of both vRNA (viral RNA) and cRNA (complementary RNA) synthesis. pppApG can be used for influenza virus research[1].

Product Specifications

CAS Number

[68892-47-7]

UNSPSC

12352005

Target

DNA/RNA Synthesis

Type

Reference compound

Related Pathways

Cell Cycle/DNA Damage

Applications

COVID-19-anti-virus

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/pppapg.html

Solubility

10 mM in DMSO

Smiles

O[C@H]([C@@H]1O[P](OC[C@H]([C@H]2O)O[C@](N3C(NC(N)=NC4=O)=C4N=C3)([H])[C@@H]2O)(O)=O)[C@](O[C@@H]1CO[P](O[P](O[P](O)(O)=O)(O)=O)(O)=O)([H])N5C6=NC=NC(N)=C6N=C5

Molecular Formula

C20H28N10O20P4

Molecular Weight

852.39

References & Citations

[1]Te Velthuis AJ, et al. Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis. Nat Rev Microbiol. 2016 Aug;14 (8) :479-93.